현장이야기 : 사모코너 ; 칠전팔기의 삶

최선옥 기독교대한성결교회 활천사 2003 활천 Vol.590 No.-

한약학 특강

최선옥,정혜인,이지민,정경림,이화경,강춘심 이화여자대학교 약학회 1989 梨花藥學會誌 Vol.- No.28

장애인의 사회적 배제와 성년후견제도 : 특정후견을 중심으로

최선옥,임소연,이현정 한국장애학회 2017 한국장애학 Vol.2 No.1

This research analyzed real operation of adult guardianship system which was newly implemented in 2013 and focused on the particular guardianship system. The particular guardian of adult guardianship system is the supporter to help the individuals with problems of self-determination specially developmental disabilities. And specially particular guardship system isn't operated by family member, so it reveals the perspectives of society to the disabilities. As a result, Adult Guardianship System is operated two-way not the three-way of the comprehensive guardianship, limited guardianship and particular guardianship. If there is a family member able to protect the individuals with problems of self-determination, limited guardianship will be implemented. If not, particular guardianship will be implemented regardless of the ability of self-determination. And during the court process, There is not a proper procedure to measure of the ability of self-determination. As a result, The real role of the public guardian is basically not balanced to their duty from the court. Because they should conduct comprehensive and multiple role, there is a possibility to get in the right of the self-determination of the disabilities. So network of the community support groups and effort to suppert and control and make people know about individuals with problems of self-determination and adult guardianship system. In this paper, I proposed more study and debate on the measure of the ability of self-determination as well as guardians' training and support. 본 연구는 2013년부터 시행되고 있는 성년후견제도가 발달장애인을 대상으로 실제로 어떻게 운용되고 있는지를 후견 유형 중 특정후견을 중심으로 살펴보는 데 목적이 있다. 이를 위해 법이 규정한 특정후견 제도와 연구자가 실제로 특정후견을 운용한 경험을 비판적 관점에서 비교하고 분석하였다. 발달장애인은 자기결정권을 행사하는 데 있어 장애인 가운데서도 특히 사회적 배제의 대상이 되어왔다. 따라서 발달장애인의 인권과 자기결정권을 보호해야 할 성년후견제도가 과연 그 목적에 맞게 운용되고 있는지 살펴보는 것은 중요하다. 특히 특정후견은 가족이나 친족이 아닌, 제3자가 후견인으로 선임될 수 있어 장애인을 바라보는 사회적 시각을 가장 잘 드러낸다고 할 수 있다. 연구 결과, 발달장애인을 위한 성년후견제도는 피성년후견인의 의사결정 능력 정도와는 크게 상관없이 가족이나 친족 등이 후견인이 되는 경우에는 한정후견으로, 가족 이외의 제3자가 후견인이 되는 경우에는 대부분 특정후견으로 심판 청구되는 것으로 나타났다. 또, 법에 규정한 본래의 취지대로라면 심판 과정에서 피성년후견인의 의사결정 능력 정도를 다차원적으로 판단하여 지원이 필요한 부분을 파악해야 하나, 실제 운용에 있어서는 합리적인 절차 없이 후견인이 선임되는 것으로 나타났다. 이로 인해 특정후견을 선임받은 공공후견인은 가정법원으로부터 ‘부여받은 임무’와 ‘실제 활동’의 불일치를 경험하게 된다고 분석할 수 있다. 더 나아가 공공후견인들이 가정법원에서 부여받은 것 이상으로 광범위하고 복합적인 역할들을 자유재량에 따라 수행하게 됨으로써 발달장애인의 자기결정권을 침해할 가능성이 높은 것으로 나타났다. 따라서 향후 성년후견제도에 서 후견 유형을 결정함에 있어 피성년후견인의 의사결정 능력을 판단하고 고려하기 위한 논의가 필요하다는 것과 교육 기관과 지역사회 등을 자원화하여 공공후견인의 활동을 지원하고 역량을 강화할 것을 제안하였다.

한국 통일교육 변천요인에 관한 연구

최선옥 북한학회 2005 북한학보 Vol.30 No.-

초등학생의 스트레스 대처를 위한 독서치료 사례연구

최선옥,한윤옥,Choi, Sun-Ok,Han, Yoon-Ok 한국비블리아학회 2006 한국비블리아학회지 Vol.17 No.1

The bibliotherapy program was carried out in the 'S' elementary school in Kyonggi province. Korea for the fourth grader children in order to measure the grade of stresses which they experience and coping styles. and to find what kind of changes in terms of the grade of stress and coping styles over stress through the bibliotherapy program. Especially, it was going to understand elementary school children's stresses and coping styles, and verify effects of the bibliotherapy program as a device of helping amicable adoption for the various stress which they experience, and they come to experience.

국소용 후발의약품의 생물학적동등성시험을 위한 가이드라인

최선옥,정성희,엄소영,정서정,김주일,정수연 한국약제학회 2004 Journal of Pharmaceutical Investigation Vol.34 No.4

A new medical system of separation of dispensary from medical practice was started in 2000 in Korea. To expand bioequivalence-proven drug products and to ensure the credibility of the therapeutic equivalence of generic drug are hot issues in Korea. The KFDA also has a plan to revise the pharmaceutical affairs law that bioequivalence reports of all the generic prescription drugs should be submitted to the KFDA in the application for drug approval. Therefore, it becomes more necessary to develop bioequivalence-demonstrating methods for specific preparations such as topical drug products. There are some differences between US and Japanese guidances of bioequivalence studies of generic drug products for topical use. In this paper, we examined the recently published Japanese guideline, Guideline for Bioequivalence Studies of Generic Products For Topical Uses, and Q&A of the guideline, which will be references to make a guidance on bioequivalence studies of topical drug products in Korea.

자본재산업(일반기계산업 위주)의 현황 및 주요추진시책에 관한 보고

최선옥 경상대학교 경영대학원 2001 最高管理者課程論文集 Vol.19 No.

생체이용률에 미치는 음식물의 영향 및 식후 생물학적 동등성시험

최선옥,정성희,엄소영,정서정,김주일,정수연 한국약제학회 2004 Journal of Pharmaceutical Investigation Vol.34 No.3

A new medical system was started in Korea in 2000 and pharmaceutical affairs law was revised in 2001. According to the revised law, generic substitution is permitted only to the drug products which are proven to be bioequivalent to the reference listed drugs. To expand the list of bioequivalence-proven drug products and to ensure the credibility of the therapeutic equivalence of generic drug are the hot issues in Korea. Also, the KFDA has a plan to revise the pharmaceutical affairs law that bioequivalence reports of all the generic prescription drug products should be submitted to the KFDA for drug approval after July in 2004. Therefore, it is increasing the necessity to develop the bioequivalence-demonstrating methods for specific drug substances and preparations which require to conduct food-effect bioavailability or bioequivalence study. There are some differences between US and Japanese guidances of food-effect bioavailability and bioequivalence studies. In this paper, we examined the recently published US guidance about food-effect study and it will be a reference to make our own guidance about food-effect bioavailability and bioequivalence guidances in Korea.

한약학 특강

최선옥,정혜인,이지민,정경림,이화경,강춘심 이화여자대학교약학회 1989 梨花藥學硏究 Vol.- No.28

X-선상에 의한 선천성 치아이상의 발생빈도에 관한 통계학적 연구

崔善鈺,李鐘甲 大韓小兒齒科學會 1980 大韓小兒齒科學會誌 Vol.7 No.1

This study was undertaken in order to observe the prevalence of congenital dental anomalies especially that of oligodontia and supernumerary teeth in 1024 children at age from 4 to 14 years, through history taking, oral examinations, roentgenographic observations of subjects, and statistic analysis was made. The following results were obtained: 1. The prevalence of oligodintia in 1024 children was 6.45±.8 percent with a total of 122 teeth absent in sixty-six subjects, excluding 3rd molars, and most of children (86.4%) who have congenitally missing teeth showed abscence of one or two teeth individually. 2. The teeth most frequently absent were the mandibular second premolar, maxillary second premolar, maxillary lateral incisor, mandibular central incisor, and mandibular lateral incisor in order. 3. There was no statistically significant difference found in tooth abscence in the following comparisons. · Male vs Female · Bilateral vs Unilateral · Maxilla vs Mandible · Right vs Left 4. The prevalence of supernumerary teeth in 1024 children was 4.79±.67 percent with a total of 59 supernumerary teeth in forty-nine subjects, all of children who have supernumerary teeth showed one or two supernumerary teeth individually. 5. Statistically significant difference was found in supernumerary teeth in the comparison of male vs female, and they were more frequent in male.